Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemia
- 6 June 1994
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 96 (6) , S45-S54
- https://doi.org/10.1016/0002-9343(94)90232-1
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemiaThe American Journal of Cardiology, 1992
- A multicenter double-blind study comparing lovastatin and gemfibrozil in the treatment of primary hypercholesterolemiaAtherosclerosis, 1991
- Long-term safety and efficacy profile of simvastatinThe American Journal of Cardiology, 1991
- Expanded clinical evaluation of lovastatin (EXCEL) study results II. Assessment of the human lens after 48 weeks of treatment with lovastatinThe American Journal of Cardiology, 1991
- A Comparative Review of the Adverse Effects of Treatments for HyperlipidaemiaDrug Safety, 1991
- Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter studyThe American Journal of Cardiology, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particlesBiochemical and Biophysical Research Communications, 1987
- Gemfibrozil in the Treatment of Dyslipidaemia A 5‐year follow‐up studyActa Medica Scandinavica, 1982